Your session is about to expire
← Back to Search
Behavioural Intervention
Enhanced Monitoring for Sepsis
N/A
Waitlist Available
Led By Mark Nunnally, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 36 months
Awards & highlights
Study Summary
This trial will help determine if using a sepsis predictive analytic tool can help save lives by reducing mortality.
Who is the study for?
This trial is for any inpatient at NYU Langone Health System who may be at risk of developing sepsis. It's not open to those who aren't inpatients there.Check my eligibility
What is being tested?
The study tests if monitoring vital signs and confusion more closely using the CAM-ICU method can help diagnose sepsis earlier, aiming to reduce mortality by following international guidelines promptly.See study design
What are the potential side effects?
Since this trial involves enhanced monitoring rather than medication, traditional side effects are not expected. However, increased monitoring could lead to anxiety or discomfort from frequent checks.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 36 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~36 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of in-hospital mortalities
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Vital Signs at 2 Hours + CAM-ICUExperimental Treatment2 Interventions
enhanced vital sign and delirium monitoring in patients for who the per-sepsis algorithm reaches alert threshold.
Group II: No InterventionActive Control1 Intervention
No intervention. Patient treated per standard of care.
Find a Location
Who is running the clinical trial?
NYU Langone HealthLead Sponsor
1,368 Previous Clinical Trials
832,226 Total Patients Enrolled
2 Trials studying Sepsis
79 Patients Enrolled for Sepsis
Mark Nunnally, MDPrincipal InvestigatorNYU Langone Health
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Vital Signs at 2 Hours + CAM-ICU
- Group 2: No Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there opportunities to participate in this experiment currently available?
"As indicated on clinicaltrials.gov, this particular trial is no longer recruiting participants; it was initially posted on June 1st 2023 and amended for the last time on August 8th 2022. However, there are 169 other medical trials currently accepting enrolment from volunteers."
Answered by AI
What requirements must an individual fulfill to be allowed to join this research experiment?
"This medical investigation requires 7500 participants aged 18 to 110 who have pyemia and are currently admitted at NYU Langone Health System."
Answered by AI
Is this clinical experiment open to individuals who are in their mid-fifties or older?
"As set out in the study terms, individuals between 18 and 110 years old are eligible to take part."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger